Source Legend
- Human-provided
Entered or confirmed by an authorized person.
- Google
Imported Google information.
- Trial-derived
Calculated or extracted directly from associated trial records.
- AI-inferred
A capability inferred from trial history.
- AI-extracted
An explicit statement extracted from an official source.
- Public registry
Information from a public registry.
- Site record
Information held in the site record.
Source: Site record. Maria Skłodowska-Curie National Research Institute of Oncology- Warsaw

Claim This Site
Are you the site administrator? Claim this site to update information.
Basic Information
Site Overview
The Maria Skłodowska-Curie National Research Institute of Oncology is one of Poland’s leading centers for cancer research, treatment, and education. Named after the renowned scientist Marie Skłodowska-Curie, the institute plays a vital role in advancing oncology through innovative research and high-quality clinical care. It operates major branches in Warsaw, Gliwice, and Kraków, offering comprehensive cancer diagnosis, therapy, and rehabilitation services. The institute is also deeply involved in clinical trials, contributing to the development of new therapeutic approaches and improving patient outcomes. In addition to its medical services, it serves as a key academic hub, training healthcare professionals and researchers in oncology-related fields. By integrating scientific research with patient-centered care, the institute significantly contributes to national and international efforts to combat cancer.
Conditions
Sponsors
Imaging & Diagnostics
Imaging and diagnostic capabilities inferred from trial participation
Laboratory & Biospecimens
Laboratory and biospecimen capabilities inferred from trial participation
Research Pharmacy & Investigational Product
Investigational-product capabilities inferred from trial participation
Clinical Procedures
Clinical procedures inferred from trial participation
Accessibility & Parking
Accessibility Features
Additional Capabilities
Other capabilities inferred from trial participation